Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses.

Enosi Tuipulotu D, Fumian TM, Netzler NE, Mackenzie JM, White PA.

Viruses. 2019 May 30;11(6). pii: E496. doi: 10.3390/v11060496.


Antiviral Candidates for Treating Hepatitis E Virus Infection.

Netzler NE, Enosi Tuipulotu D, Vasudevan SG, Mackenzie JM, White PA.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00003-19. doi: 10.1128/AAC.00003-19. Print 2019 Jun.


Norovirus antivirals: Where are we now?

Netzler NE, Enosi Tuipulotu D, White PA.

Med Res Rev. 2019 May;39(3):860-886. doi: 10.1002/med.21545. Epub 2018 Dec 25. Review.


Potential Therapeutic Agents for Feline Calicivirus Infection.

Fumian TM, Tuipulotu DE, Netzler NE, Lun JH, Russo AG, Yan GJH, White PA.

Viruses. 2018 Aug 16;10(8). pii: E433. doi: 10.3390/v10080433.


Emerging recombinant noroviruses identified by clinical and waste water screening.

Lun JH, Hewitt J, Sitabkhan A, Eden JS, Enosi Tuipulotu D, Netzler NE, Morrell L, Merif J, Jones R, Huang B, Warrilow D, Ressler KA, Ferson MJ, Dwyer DE, Kok J, Rawlinson WD, Deere D, Crosbie ND, White PA.

Emerg Microbes Infect. 2018 Mar 29;7(1):50. doi: 10.1038/s41426-018-0047-8.


TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.

Enosi Tuipulotu D, Netzler NE, Lun JH, Mackenzie JM, White PA.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02417-17. doi: 10.1128/AAC.02417-17. Print 2018 May.


In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase.

Ferla S, Netzler NE, Ferla S, Veronese S, Tuipulotu DE, Guccione S, Brancale A, White PA, Bassetto M.

Sci Rep. 2018 Mar 7;8(1):4129. doi: 10.1038/s41598-018-22303-y.


RNA Sequencing of Murine Norovirus-Infected Cells Reveals Transcriptional Alteration of Genes Important to Viral Recognition and Antigen Presentation.

Enosi Tuipulotu D, Netzler NE, Lun JH, Mackenzie JM, White PA.

Front Immunol. 2017 Aug 11;8:959. doi: 10.3389/fimmu.2017.00959. eCollection 2017.


Broad-spectrum non-nucleoside inhibitors for caliciviruses.

Netzler NE, Enosi Tuipulotu D, Eltahla AA, Lun JH, Ferla S, Brancale A, Urakova N, Frese M, Strive T, Mackenzie JM, White PA.

Antiviral Res. 2017 Oct;146:65-75. doi: 10.1016/j.antiviral.2017.07.014. Epub 2017 Jul 27.


Ancient recombination events and the origins of hepatitis E virus.

Kelly AG, Netzler NE, White PA.

BMC Evol Biol. 2016 Oct 12;16(1):210.


Purification and Biochemical Characterisation of Rabbit Calicivirus RNA-Dependent RNA Polymerases and Identification of Non-Nucleoside Inhibitors.

Urakova N, Netzler N, Kelly AG, Frese M, White PA, Strive T.

Viruses. 2016 Apr 14;8(4):100. doi: 10.3390/v8040100.


Gain-of-function phenotypes of many CLAVATA3/ESR genes, including four new family members, correlate with tandem variations in the conserved CLAVATA3/ESR domain.

Strabala TJ, O'donnell PJ, Smit AM, Ampomah-Dwamena C, Martin EJ, Netzler N, Nieuwenhuizen NJ, Quinn BD, Foote HC, Hudson KR.

Plant Physiol. 2006 Apr;140(4):1331-44. Epub 2006 Feb 17.


Cell-to-cell movement of potexviruses: evidence for a ribonucleoprotein complex involving the coat protein and first triple gene block protein.

Lough TJ, Netzler NE, Emerson SJ, Sutherland P, Carr F, Beck DL, Lucas WJ, Forster RL.

Mol Plant Microbe Interact. 2000 Sep;13(9):962-74.

Supplemental Content

Loading ...
Support Center